GSK acquires 10% stake in CureVac, partner on mRNA vaccines
GSK pushes to broaden its infectious disease pipeline by agreeing development deal with CureVac for five candidates.
Archives for July 20, 2020
Merck KGaA takes up option to license bispecific antibody
The company opts into its second bispecific antibody through its partnership with F-star Therapeutics.
J&J to start P3 COVID-19 vaccine trials in September
Moving on an accelerated timeline, the company seeks late September start date and to exceed 1bn doses by end of 2021.